Jay Chhablani MD is Professor of Ophthalmology and vitreo-retina surgeon at the University of Pittsburgh Eye Center, USA. He established the “Choroid Analysis and Research (CAR) Lab,” which focuses on computational as well as biological research in the field of choroid. He has published more than 650 articles in peer-reviewed journals with a focus in the field of choroid. He is the editor of books “Choroidal Disorders,” “Central Serous Chorioretinopathy” and “Choroidal Neovascularization.” He is on the editorial board of several journals, including the American Journal of Ophthalmology. He has won several national and international awards and delivered named lectures. As a board-certified ophthalmologist, Caroline R. Baumal MD, FASRS has authored over 170 publications and has been recognized with numerous prestigious awards, including the Senior Achievement Award from the American Academy of Ophthalmology, the Crystal Apple Award from the American Society of Retina Specialists, and the Lifetime Achievement Award from the Vit-Buckle Society. She also has been involved with research and clinical trials investigating novel therapies for retinal diseases. Caroline studied biochemistry at McGill University and received an MD from the University of Toronto, where she also completed her ophthalmology residency followed by two fellowships: Retinal Surgery at Wills Eye Hospital and Medical Retinal and Lasers at New England Eye Center.

Select Guide Rating

• 1. Definitions2. Histopathology and mechanisms3. Epidemiology and risk factors including genetics4. Non-dye-based imaging, Fundus photo, IR, FAF5. OCT6. OCTA7. Dye-based imaging (FA, ICG)8. Visual Function test (electrophysiology, dark adaptation, etc)9. Differential diagnosis and masquerades10. GA progression11. GA association with CNV12. Role of AI in diagnosis and follow-up13. GA management (prevention, old treatments, new treatments with side effects, Visual cycle modulators, mTOR inhibitors, complement inhibitors, MMP inhibitors, LDL lowering drugs, Anti-amyloid beta, Antioxidants and neuroprotectants; Choroidal perfusion enhancers14. GA management (Surgical approaches)15. Failed approaches in GA16. Learnings from GA clinical trials17. Burden of disease, visual rehabilitation, Psychosocial Impact18. Personalized medicine in GA: The future is here